{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:53:58Z","timestamp":1781607238002,"version":"3.54.5"},"reference-count":28,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Feline Infectious Peritonitis (FIP) has been transformed from a fatal disease to a treatable condition following the introduction of GS-441524, a nucleoside analogue targeting feline coronavirus replication. However, the widespread use of unregulated compounded formulations and the absence of validated analytical tools for therapeutic drug monitoring (TDM) represent critical gaps in clinical FIP management. This study describes the development and full ICH M10-compliant validation of a high-throughput LC-MS\/MS method for the quantification of GS-441524 in feline serum, incorporating an automated protein precipitation protocol and a PBS-BSA surrogate matrix in accordance with 3Rs principles. The method met all acceptance criteria across validated parameters, including linearity (0.1\u201350 \u00b5g\/mL), accuracy (bias within \u00b112.5%), precision (CV \u2264 10.9%), selectivity, extraction recovery (87.5\u2013107.9%), and stability under clinically relevant storage conditions. Matrix equivalence between PBS-BSA and authentic feline serum was confirmed, enabling routine calibration without animal-derived materials. The validated method was applied to clinical TDM in cats undergoing GS-441524 treatment for FIP, providing preliminary evidence of inter-individual pharmacokinetic variability. The compounded formulations administered to the TDM cohort were independently verified by LC-MS\/MS, confirming drug content within \u00b115% of labelled claims and excluding pharmaceutical quality as a confounding factor in the interpretation of serum drug concentrations.<\/jats:p>","DOI":"10.3390\/ani16121851","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:06:52Z","timestamp":1781600812000},"page":"1851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LC-MS\/MS Therapeutic Drug Monitoring of GS-441524 in Serum and Various Compounded Formulations to Improve the Treatment of Feline Infectious Peritonitis"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2192-4336","authenticated-orcid":false,"given":"Riccardo","family":"Masti","sequence":"first","affiliation":[{"name":"San Marco Veterinary Clinic and Laboratory, Via dell\u2019Industria 3, 35030 Veggiano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Marin","sequence":"additional","affiliation":[{"name":"San Marco Veterinary Clinic and Laboratory, Via dell\u2019Industria 3, 35030 Veggiano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Magna","sequence":"additional","affiliation":[{"name":"San Marco Veterinary Clinic and Laboratory, Via dell\u2019Industria 3, 35030 Veggiano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-221X","authenticated-orcid":false,"given":"Francesca Maria","family":"Bertolini","sequence":"additional","affiliation":[{"name":"San Marco Veterinary Clinic and Laboratory, Via dell\u2019Industria 3, 35030 Veggiano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1935-5146","authenticated-orcid":false,"given":"Tommaso","family":"Furlanello","sequence":"additional","affiliation":[{"name":"San Marco Veterinary Clinic and Laboratory, Via dell\u2019Industria 3, 35030 Veggiano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/0300985814522077","article-title":"Feline Infectious Peritonitis: Still an Enigma?","volume":"51","author":"Kipar","year":"2014","journal-title":"Vet. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"14122","DOI":"10.1128\/JVI.79.22.14122-14130.2005","article-title":"Acquisition of Macrophage Tropism during the Pathogenesis of Feline Infectious Peritonitis Is Determined by Mutations in the Feline Coronavirus Spike Protein","volume":"79","author":"Rottier","year":"2005","journal-title":"J. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jfms.2008.09.008","article-title":"A Review of Feline Infectious Peritonitis Virus Infection: 1963\u20132008","volume":"11","author":"Pedersen","year":"2009","journal-title":"J. Feline Med. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.bmcl.2012.02.105","article-title":"Synthesis and Antiviral Activity of a Series of 1\u2019-Substituted 4-Aza-7,9-Dideazaadenosine C-Nucleosides","volume":"22","author":"Cho","year":"2012","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][Triazin-4-Amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The Nucleoside Analog GS-441524 Strongly Inhibits Feline Infectious Peritonitis (FIP) Virus in Tissue Culture and Experimental Cat Infection Studies","volume":"219","author":"Murphy","year":"2018","journal-title":"Vet. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gokalsing, E., Ferrolho, J., Gibson, M.S., Vilhena, H., and Anast\u00e1cio, S. (2025). Efficacy of GS-441524 for Feline Infectious Peritonitis: A Systematic Review (2018\u20132024). Pathogens, 14.","DOI":"10.3390\/pathogens14070717"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/1098612X221118761","article-title":"2022 AAFP\/EveryCat Feline Infectious Peritonitis Diagnosis Guidelines","volume":"24","author":"Thayer","year":"2022","journal-title":"J. Feline Med. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Tasker, S., Spiri, A.M., Hartmann, K., Addie, D.D., Bel\u00e1k, S., Bergmann, M., Egberink, H., Frymus, T., Hofmann-Lehmann, R., and Marsilio, F. (2026). Update on Treatment of Feline Infectious Peritonitis: European Advisory Board on Cat Diseases (ABCD) Guidelines. Viruses, 18.","DOI":"10.3390\/v18040452"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1098612X231194460","DOI":"10.1177\/1098612X231194460","article-title":"Retrospective Study and Outcome of 307 Cats with Feline Infectious Peritonitis Treated with Legally Sourced Veterinary Compounded Preparations of Remdesivir and GS-441524 (2020\u20132022)","volume":"25","author":"Taylor","year":"2023","journal-title":"J. Feline Med. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.2023.2246553","article-title":"Quantification of GS-441524 Concentration in Feline Plasma Using High Performance Liquid Chromatography with Fluorescence Detection","volume":"43","author":"Kimble","year":"2023","journal-title":"Vet. Q."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jsap.13849","article-title":"Pharmacokinetics of GS-441524 Following Intravenous Remdesivir in Six Cats and Results of Therapeutic Drug Monitoring during Treatment of Feline Infectious Peritonitis: 22 Cases (2021\u20132024)","volume":"66","author":"Coggins","year":"2025","journal-title":"J. Small Anim. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cooke, S.W., Hammond, R., and Gunn-Moore, D.A. (2026). Therapeutic Drug Monitoring of GS-441524 in Cats with Feline Infectious Peritonitis: Pharmacokinetic Variability and Implications for Dose Optimization. Pathogens, 15.","DOI":"10.20944\/preprints202601.0788.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jsap.13869","article-title":"High-dose Induction Therapy and Treatment Termination Criteria for Feline Infectious Peritonitis with Remdesivir, GS -441524 and Adjunctive Mefloquine: 46 Cases (2023)","volume":"66","author":"Kamiyoshi","year":"2025","journal-title":"J. Small Anim. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"124996","DOI":"10.1016\/j.talanta.2023.124996","article-title":"Overview of Therapeutic Drug Monitoring and Clinical Practice","volume":"266","author":"Fang","year":"2024","journal-title":"Talanta"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Bardhi, A., Lanci, A., Mannini, A., Castagnetti, C., and Barbarossa, A. (2025). A Laboratory Protocol for Routine Therapeutic Drug Monitoring of Beta-Lactams Antimicrobials in Horses and Dogs. Antibiotics, 14.","DOI":"10.3390\/antibiotics14040390"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2011.09.041","article-title":"Therapeutic Drug Monitoring and LC\u2013MS\/MS","volume":"883\u2013884","author":"Adaway","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00216-021-03583-2","article-title":"Mass Spectrometry Based High-Throughput Bioanalysis of Low Molecular Weight Compounds: Are We Ready to Support Personalized Medicine?","volume":"414","author":"Hopfgartner","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_19","unstructured":"(2022). ICH Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1021\/ac5018265","article-title":"Selecting the Correct Weighting Factors for Linear and Quadratic Calibration Curves with Least-Squares Regression Algorithm in Bioanalytical LC-MS\/MS Assays and Impacts of Using Incorrect Weighting Factors on Curve Stability, Data Quality, and Assay Performance","volume":"86","author":"Gu","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array Programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: Fundamental Algorithms for Scientific Computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D Graphics Environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC\u2212MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/17576180.2024.2416360","article-title":"The Use of Surrogate Matrices in Bioanalytical Preclinical Safety Testing Using Chromatographic Methods: A Recommendation from the European Bioanalysis Forum","volume":"16","author":"Goodwin","year":"2024","journal-title":"Bioanalysis"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Grimm, H., Biller-Andorno, N., Buch, T., Dahlhoff, M., Davies, G., Cederroth, C.R., Maissen, O., Lukas, W., Passini, E., and T\u00f6rnqvist, E. (2023). Advancing the 3Rs: Innovation, Implementation, Ethics and Society. Front. Vet. Sci., 10.","DOI":"10.3389\/fvets.2023.1185706"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Li, W., Zhang, J., and Tse, F.L.S. (2013). Use of Internal Standards in LC-MS Bioanalysis. Handbook of LC-MS Bioanalysis, Wiley.","DOI":"10.1002\/9781118671276"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/phar.70013","article-title":"Pharmacokinetic Approaches to Standardize Antiviral Exposure in Cerebrospinal Fluid","volume":"45","author":"Avedissian","year":"2025","journal-title":"Pharmacotherapy"}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/12\/1851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:09:42Z","timestamp":1781604582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/16\/12\/1851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ani16121851"],"URL":"https:\/\/doi.org\/10.3390\/ani16121851","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}